Effect of antispasmodic drug on endoscopic ultrasonography-a multicencer randomized comparative trial
Not Applicable
- Conditions
- pancreatobiliary disease necessary for EUS or EUS-FNA
- Registration Number
- JPRN-UMIN000008047
- Lead Sponsor
- Hokkaido university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Refusal to provide informed consent (2)Poor general status (performance status 4: completely disabled, cannot perform any self-care, and totally confined to the bed) (3)Younger than age 20 years (4)Incapability of insertion of echoendoscope (5)Severe heart or pulmonary dysfunction (6)Pregnancy (7)Use of antispasmodic drugs (within 12 h) before EUS/EUS-FNA (8)Patients with bleeding tendency (9)Patients with hemorrhagic colitis, glaucoma, benign prostat hyperplasia, paralytic ileus, pheocromocytoma or allergy for butylscoporamine or glucagon (10)Judged inappropriate by a doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method